
GEHC Stock Forecast & Price Target
GEHC Analyst Ratings
Bulls say
GE HealthCare Techs is a leader in the medical technology industry, with a diverse portfolio of imaging, visualization, and patient care solutions that make up almost 90% of their revenue. The remaining recurring revenue from servicing, pharmaceutical diagnostics, and digital solutions provides stability. Despite some potential challenges and regulatory compliance issues, their focus on innovation, recent acquisitions, and global expansion make them a strong investment opportunity with potential for growth in the future.
Bears say
GE HealthCare Techs is facing significant challenges in the short term due to tariffs and inflation, as well as competition in the total-body imaging market from traditional rivals and new entrants. Although the company has a strong focus on innovation and R&D, as well as a diverse geographic revenue mix, it may struggle to maintain its EBIT margin in the face of these challenges. Additionally, while they have recently introduced new products and technologies, the success of these launches and partnerships is uncertain in the highly competitive medical technology industry.
This aggregate rating is based on analysts' research of GE HealthCare Technologies Inc and is not a guaranteed prediction by Public.com or investment advice.
GEHC Analyst Forecast & Price Prediction
Start investing in GEHC
Order type
Buy in
Order amount
Est. shares
0 shares